1st Edition
Gene Regulation and Therapeutics for Cancer
Differential gene regulation and targeted therapy are the critical aspects of several cancers. This book covers specific gene regulation and targeted therapies in different malignancies. It offers a comprehensive assessment of the transcriptional dysregulation in cancer, and considers some examples of transcriptional regulators as definitive oncogenic drivers in solid tumors, followed by a brief discussion of transcriptional effectors of the programs they drive, and discusses its specific targets. Most targeted therapeutics developed to date have been directed against a limited set of oncogenic drivers, exemplified by those encoding cell surface or cytoplasmic kinases that function in intracellular signaling cascades.
Programmed Death 1 Receptor (PD-1)-mediated Immunomodulatory Effects in Pancreatic Cancer
Ashu Shah, Catherine Orzechowski and Maneesh Jain
Nuclear Factor Kappa-B: Bridging Inflammation and Cancer
Mohammad Aslam Khan, Girijesh Kumar Patel, Haseeb Zubair, Nikhil Tyagi, Shafquat Azim, Seema Singh, Aamir Ahmad and Ajay Pratap Singh
The S100A7/8/9 Proteins: Novel Biomarker and Therapeutic Targets for Solid Tumor Stroma
Sanjay Mishra, Dinesh Ahirwar, Mohd W. Nasser and Ramesh K. Ganju
Nuclear Receptor Coactivators: Mechanism and Therapeutic Targeting In Cancer
Andrew Cannon, Christopher Thomson, Rakesh Bhatia and Sushil Kumar
Liquid Biopsies for Pancreatic Cancer: A Step Towards Early Detection
Joseph Carmicheal, Rahat Jahan, Koelina Ganguly, Ashu Shah and Sukhwinder Kaur
Targeting Subgroup-specific Cancer Epitopes for Effective Treatment of Pediatric Medulloblastoma
Sidharth Mahapatra and Naveen Kumar Perumal
Aberrant Methylation of UC Promoters in Human Pancreatic Ductal Carcinomas
Michiyo Higashi and Seiya Yokoyama
Receptor Tyrosine Kinase Signaling Pathways as a Goldmine for Targeted Therapy in Head and Neck Cancers
Muzafar A. Macha, Satyanarayana Rachagani, Sanjib Chaudhary, Zafar Sayed, Dwight T. Jones and Surinder K. Batra
Molecular Drivers in Lung Adenocarcinoma: Therapeutic Implications
Imayavaramban Lakshmanan and Apar Kishor Ganti
Molecular Mediator of Prostate Cancer Progression and Its Implication in Therapy
Samikshan Dutta, Navatha Shree Sharma, Ridwan Islam and Kaustubh Datta
Therapeutic Options for Prostate Cancer: A Contemporary Update
Sakthivel Muniyan, Jawed A. Siddiqui and Surinder K. Batra
Regulation and Targeting of MUCINS in Pancreatic Cancer
Shailendra K. Gautam, Grish C. Varshney and Parthasarathy Seshacharyulu
Targeted Therapy for Cancer Stem Cells
Rama Krishna Nimmakayala, Saswati Karmakar, Garima Kaushik, Sanchita Rauth, Srikanth Barkeer and Moorthy P. Ponnusamy
Biography
Surinder K. Batra is a Professor and Chairman of the Department of Biochemistry and Molecular Biology at the University of Nebraska Medical Center. Dr. Batra studies the functions of mucins in the progression of different malignancies. His recent studies demonstrated the molecular mechanism for the progression and metastasis of multiple cancers. His investigations led to developing several targeted therapies for different tumors. Based on his mechanistic and translational studies, different targets entered into Phase I/II trials for various cancers.
Moorthy P. Ponnusamy is an Associate Professor of Biochemistry and Molecular Biology at the University of Nebraska Medical Centre. Dr. Ponnusamy’s research background reflects a keen interest in understanding the molecular mechanisms of cancer stem cell-mediated progression and metastatis of pancreatic cancer. His recent studies discovered the specific mechanism for pancreatic cancer stem cell maintenance and its impact on metastatis. He is developing small molecules to target cancer stem cell populations.
"The book discusses the specific genes that regulate several malignancies and the available and optimized targeted therapies to treat such cancers. This is an excellent book that provides an interesting account on transcriptional dysregulation in cancer and how transcriptional regulation by therapeutic agents serves as a platform to design clinical trials in the questof cures for cancer. It is quite unique in discussing this complex subject matter concisely and clearly."
- Omer Iqbal, Loyola University Medical Center
